Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVONEX for Ulcerative Colitis
NCT00048347Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2002
- Primary completion
- Jun 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1a in ulcerative colitis (UC), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2002; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00048347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048347.